AU2002221131A1 - Blood lipid ameliorant composition - Google Patents

Blood lipid ameliorant composition

Info

Publication number
AU2002221131A1
AU2002221131A1 AU2002221131A AU2113102A AU2002221131A1 AU 2002221131 A1 AU2002221131 A1 AU 2002221131A1 AU 2002221131 A AU2002221131 A AU 2002221131A AU 2113102 A AU2113102 A AU 2113102A AU 2002221131 A1 AU2002221131 A1 AU 2002221131A1
Authority
AU
Australia
Prior art keywords
ameliorant
composition
blood lipid
lipid
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221131A
Other languages
English (en)
Inventor
Tatsuhito Kondo
Masato Nakayama
Tsuneoki Ohsawa
Ippei Shimizu
Ikuo Takagi
Yasuhiro Torizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2002221131A1 publication Critical patent/AU2002221131A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002221131A 2000-12-14 2001-12-12 Blood lipid ameliorant composition Abandoned AU2002221131A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-379879 2000-12-14
JP2000379879 2000-12-14
PCT/JP2001/010914 WO2002047682A1 (fr) 2000-12-14 2001-12-12 Composition ameliorant les lipides sanguins

Publications (1)

Publication Number Publication Date
AU2002221131A1 true AU2002221131A1 (en) 2002-06-24

Family

ID=18848165

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221131A Abandoned AU2002221131A1 (en) 2000-12-14 2001-12-12 Blood lipid ameliorant composition

Country Status (7)

Country Link
US (1) US7012067B2 (zh)
CN (1) CN100369605C (zh)
AU (1) AU2002221131A1 (zh)
CA (1) CA2433285C (zh)
HK (1) HK1061518A1 (zh)
TW (1) TWI277417B (zh)
WO (1) WO2002047682A1 (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284529B (en) * 2000-12-18 2007-08-01 Sankyo Co A composition for lowering triglyceride
JP2006509722A (ja) * 2002-07-03 2006-03-23 エスペリオン セラピューティクス，インコーポレイテッド 脂質代謝異常を治療するためのパンテチン含有組成物
US20050187204A1 (en) * 2002-08-08 2005-08-25 Sankyo Company, Limited Medicinal composition for lowering blood lipid level
US20050192347A1 (en) * 2003-12-23 2005-09-01 Dasseux Jean-Louis H. Urea and thiourea compounds and compositions for cholesterol management and related uses
CN1329031C (zh) * 2005-01-24 2007-08-01 杭州鑫富药业有限公司 一种调血脂药物组合物及其用途
JP5080011B2 (ja) * 2005-02-28 2012-11-21 第一三共ヘルスケア株式会社 グルタチオンペルオキシダーゼ活性を増加させるための組成物
WO2007125339A1 (en) 2006-04-26 2007-11-08 Rosemont Pharmaceuticals Ltd Liquid oral compositions
US20090076134A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched simvastatin
EP2220208A4 (en) * 2007-11-23 2010-12-29 Rappaport Family Inst For Res USE OF HAPTOGLOBIN GENOTYPING IN THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASE
WO2013100080A1 (ja) 2011-12-27 2013-07-04 国立大学法人大阪大学 iPS細胞の腫瘍化を抑制することが可能な分化誘導方法
BR112022001422A2 (pt) 2019-07-29 2022-03-22 Matthias Rath Ascorbato na prevenção da calcificação vascular induzida por estatina
US11547693B2 (en) 2019-07-29 2023-01-10 Matthias Rath Ascorbate in the prevention of statin induced vascular calcification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019891B2 (ja) * 1978-12-01 1985-05-18 第一製薬株式会社 薬物性脂肪肝用剤
JPS5869813A (ja) * 1981-10-23 1983-04-26 Sogo Yatsukou Kk 血清脂質低下剤
JPS6041611A (ja) * 1983-08-17 1985-03-05 Sankyo Co Ltd 血中脂質低下剤
US5662934A (en) * 1993-01-05 1997-09-02 Najarian; Thomas Compositions and methods for lowering cholesterol while maintaining antioxidant levels
EP0904082A4 (en) * 1996-04-17 2001-09-26 Merck & Co Inc COMBINATION THERAPY TO REDUCE THE RISKS OF HEART CIRCULAR DISEASES
AU5844196A (en) * 1996-05-29 1998-01-05 Taisho Pharmaceutical Co., Ltd. Remedy or preventive for hyperlipemia
US6245797B1 (en) * 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
UA77660C2 (en) * 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human

Also Published As

Publication number Publication date
HK1061518A1 (en) 2004-09-24
US7012067B2 (en) 2006-03-14
CN1489462A (zh) 2004-04-14
CA2433285A1 (en) 2002-06-20
CA2433285C (en) 2009-06-23
WO2002047682A1 (fr) 2002-06-20
US20040014712A1 (en) 2004-01-22
CN100369605C (zh) 2008-02-20
TWI277417B (en) 2007-04-01

Similar Documents

Publication Publication Date Title
AU2001241963A1 (en) Improved medical procedure
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU2001260327A1 (en) Chair
AU2001295657A1 (en) Formulation containing wax-esters
AU2001259702A1 (en) Tissue regrafting
AU4439701A (en) Patient support
AU2001233208A1 (en) Human sulfatases
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2002221131A1 (en) Blood lipid ameliorant composition
AU2001241098A1 (en) Composition
AUPQ761100A0 (en) Lipophilic medicament
AU2002227925A1 (en) Human beta-defensin-3
AU2001275201A1 (en) Acne-treating composition
AU4085201A (en) Pharmaceutical composition
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001247841A1 (en) Medical procedure
AU9517501A (en) Composition containing leishmania LIP2A
AU2001287852A1 (en) Composition
AU2001252200A1 (en) Chair
AU2002221130A1 (en) Blood lipid ameliorant composition
AU2001295991A1 (en) Compositions for improving lipids in blood
AUPR099200A0 (en) New formulation
AU2001287732A1 (en) Copolycarbonate-based composition
AUPR069500A0 (en) Tissue modification